NURIX THERAPEUTICS, INC. Shares Outstanding (Cover Page)
NURIX THERAPEUTICS, INC. (NRIX) had Shares Outstanding (Cover Page) of 103.78 million shares as of 2026-06-30, per its 10-Q filed 2026-07-09.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-09
- 2026-06-30: Entity Common Stock, Shares Outstanding 103.78M shares.
- 2026-04-01: Entity Common Stock, Shares Outstanding 103.41M shares.
- 2026-01-23: Entity Common Stock, Shares Outstanding 102.84M shares.
- 2025-09-30: Entity Common Stock, Shares Outstanding 76.88M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-06-30 | 103.78M shares 10-Q · filed 2026-07-09 |
| 2026-04-01 | 103.41M shares 10-Q · filed 2026-04-08 |
| 2026-01-23 | 102.84M shares 10-K · filed 2026-01-28 |
| 2025-09-30 | 76.88M shares 10-Q · filed 2025-10-09 |
| 2025-06-30 | 76.45M shares 10-Q · filed 2025-07-09 |
| 2025-04-01 | 76.24M shares 10-Q · filed 2025-04-08 |
| 2025-01-24 | 75.89M shares 10-K · filed 2025-01-28 |
| 2024-10-10 | 70.84M shares 10-Q · filed 2024-10-11 |
| 2024-07-01 | 64.41M shares 10-Q · filed 2024-07-11 |
| 2024-04-01 | 49.15M shares 10-Q · filed 2024-04-10 |
| 2024-02-05 | 48.89M shares 10-K · filed 2024-02-15 |
| 2023-10-02 | 48.50M shares 10-Q · filed 2023-10-12 |
| 2023-06-30 | 48.20M shares 10-Q · filed 2023-07-13 |
| 2023-03-31 | 47.45M shares 10-Q · filed 2023-04-13 |
| 2023-01-31 | 47.27M shares 10-K · filed 2023-02-09 |
| 2022-09-30 | 47.15M shares 10-Q · filed 2022-10-06 |
| 2022-06-30 | 47.04M shares 10-Q · filed 2022-07-07 |
| 2022-03-31 | 44.95M shares 10-Q · filed 2022-04-08 |
| 2022-01-21 | 44.74M shares 10-K · filed 2022-01-28 |
| 2021-10-08 | 44.61M shares 10-Q · filed 2021-10-14 |
| 2021-07-09 | 44.43M shares 10-Q · filed 2021-07-13 |
| 2021-04-09 | 44.35M shares 10-Q · filed 2021-04-13 |
| 2021-02-11 | 38.91M shares 10-K · filed 2021-02-16 |
| 2020-10-07 | 38.86M shares 10-Q · filed 2020-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |